Krsnaa Diagnostics Limited
NSE:KRSNAA.NS
830.9 (INR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,871.23 | 4,871.23 | 4,554.5 | 3,964.56 | 2,584.27 | 2,092.35 | 1,075.7 | 568.896 |
| Cost of Revenue
| 1,553.86 | 741.79 | 602.96 | 837.47 | 277.23 | 173.36 | 764.64 | 148.734 |
| Gross Profit
| 3,317.37 | 4,129.44 | 3,951.54 | 3,127.09 | 2,307.04 | 1,918.99 | 311.06 | 420.162 |
| Gross Profit Ratio
| 0.681 | 0.848 | 0.868 | 0.789 | 0.893 | 0.917 | 0.289 | 0.739 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 654.68 | 81.49 | 64.42 | 107.88 | 65.78 | 52.34 | 175.05 | 124.971 |
| Selling & Marketing Expenses
| 297.04 | 31.91 | 18.09 | 10.33 | 12.46 | 7.89 | 3.32 | 4.69 |
| SG&A
| 951.72 | 113.4 | 82.51 | 118.21 | 78.24 | 60.23 | 161.67 | 129.66 |
| Other Expenses
| 167.96 | 193.79 | 0.02 | 0.11 | 2.13 | 0.92 | -2.55 | 0 |
| Operating Expenses
| 2,624.97 | 3,444.25 | 3,048.16 | 2,558.23 | 2,002.93 | 1,596.17 | 164.22 | 360.499 |
| Operating Income
| 692.4 | 692.39 | 903.37 | 568.78 | 304.11 | 322.82 | 146.84 | 46.602 |
| Operating Income Ratio
| 0.142 | 0.142 | 0.198 | 0.143 | 0.118 | 0.154 | 0.137 | 0.082 |
| Total Other Income Expenses Net
| 109.62 | 109.62 | -38.29 | 2,385.74 | -1,887.43 | -1,100.08 | -989.65 | -24.087 |
| Income Before Tax
| 802.01 | 802.01 | 865.1 | 2,954.52 | -1,583.32 | -777.26 | -842.81 | 22.515 |
| Income Before Tax Ratio
| 0.165 | 0.165 | 0.19 | 0.745 | -0.613 | -0.371 | -0.783 | 0.04 |
| Income Tax Expense
| 180.9 | 180.9 | 181.2 | 1,105.23 | -463.81 | -196.69 | -241.24 | 1.794 |
| Net Income
| 568.37 | 621.11 | 683.88 | 1,849.29 | -1,119.51 | -580.57 | -601.57 | -39.247 |
| Net Income Ratio
| 0.117 | 0.128 | 0.15 | 0.466 | -0.433 | -0.277 | -0.559 | -0.069 |
| EPS
| 19.78 | 19.78 | 22.89 | 58.9 | -35.66 | -18.49 | -58.27 | -3.8 |
| EPS Diluted
| 19.29 | 19.29 | 22.88 | 58.9 | -35.66 | -18.49 | -58.27 | -3.8 |
| EBITDA
| 1,442.46 | 1,416.8 | 1,450.08 | 1,055.4 | 742.97 | 593.83 | 321.92 | 144.81 |
| EBITDA Ratio
| 0.296 | 0.291 | 0.318 | 0.266 | 0.287 | 0.284 | 0.299 | 0.255 |